Brazilian researchers close to biventricular CAD trial milestone
This article was originally published in Clinica
Executive Summary
Brazilian researchers are claiming to be close to launching the country's first human trials of an implantable biventricular cardiac assist device (CAD). According to an announcement posted yesterday on the Hospitalar website, citing the Instituto Dante Pazzanese de Cardiologia, in Sao Paulo, the CAD developed in conjunction with the Fundacao Adib Jatene is about to undergo final trials in calves. Human trials can begin, reportedly, once the device demonstrates 30-day survival in at least three animals.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.